Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. WW
WW logo

WW Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
10.310
Open
9.950
VWAP
9.45
Vol
781.78K
Mkt Cap
99.96M
Low
8.910
Amount
7.38M
EV/EBITDA(TTM)
2.94
Total Shares
10.00M
EV
405.15M
EV/OCF(TTM)
--
P/S(TTM)
0.39
WW International, Inc. provides science-backed weight loss and weight management programs. The Company provides an accessible, holistic model of care through its doctor-recommended Points Program, clinical interventions including weight-loss medications, and community support. Its weight-loss and weight management programs are focused on nutritional and behavior change science. They are comprised of a range of science-based nutritional, activity, behavioral and lifestyle tools and approaches that can be tailored for individual weight goals and, if needed, support the various needs of people taking GLP-1 medications. Its offerings include Behavior Change Programs, WeightWatchers Clinic, Licensing and Consumer Product Sales. Its subscription businesses include digital business, workshops + digital business, clinical business and WeightWatchers for business offering nutritional and behavior change science. Its WW-branded products include bars, snacks, cookbooks and kitchen tools.
Show More

Events Timeline

(ET)
2026-04-20
07:40:00
WW International Appoints Heather Thiltgen to Board of Directors
select
2026-04-06 (ET)
2026-04-06
16:40:00
Major Averages Rise as US-Iran Ceasefire Talks Emerge
select
2026-04-06
12:00:00
Major Averages Broadly Higher as U.S.-Iran War May End Soon
select
2026-04-05 (ET)
2026-04-05
21:20:00
WW International Announces Leadership Changes and Governance Reforms
select
2026-03-31 (ET)
2026-03-31
07:50:00
Novo Nordisk Launches Wegovy Subscription Program, Save Up to $1200 Annually
select
2026-03-16 (ET)
2026-03-16
16:30:00
Stocks Rebound Amid Energy Market Volatility
select
2026-03-16
12:00:00
Stocks Rebound Amid Rising Oil Prices and Geopolitical Tensions
select
2026-03-16
09:00:00
Stock Futures Rise as Markets Seek Recovery
select

News

Newsfilter
5.0
04-20Newsfilter
Weight Watchers Appoints New Board Member
  • New Board Member: Weight Watchers appointed Heather Thiltgen to its Board of Directors effective April 20, 2026, bringing extensive healthcare leadership experience, which is expected to drive strategic growth for the company.
  • Professional Background: Thiltgen significantly increased revenue as CEO of WellSense Health Plan and successfully expanded market share in complex regulatory environments, which will aid Weight Watchers in enhancing access to GLP-1 therapies.
  • Board Expansion: With Thiltgen's appointment, the Weight Watchers Board now consists of six independent members, reflecting the company's ability to attract high-caliber directors aimed at advancing its evolution in a rapidly changing market.
  • Long-term Value Creation: Thiltgen expressed her eagerness to collaborate with the Board and management team to leverage Weight Watchers' science-backed approach to improve member experience and create long-term shareholder value, further solidifying the company's market leadership.
Yahoo Finance
4.5
04-09Yahoo Finance
Healthcare Stocks Mixed as NYSE Health Care Index Edges Up 0.1%
  • Mixed Market Performance: Late Thursday afternoon, healthcare stocks showed mixed results, with the NYSE Health Care Index rising by 0.1%, indicating a cautious market sentiment towards the healthcare sector amid economic uncertainties.
  • Investor Sentiment Fluctuations: While the overall index saw a slight increase, individual healthcare stocks exhibited varied performances, influenced by company earnings reports and market dynamics, highlighting the volatility and uncertainty in investor sentiment.
  • Uncertain Industry Outlook: The future of the healthcare industry faces challenges, particularly in light of changing policies and economic conditions, prompting investors to closely monitor potential impacts from regulatory changes on the sector.
  • Long-Term Trends to Watch: Despite the mixed short-term performance of healthcare stocks, the sector is still viewed as having growth potential in the long run, driven by an aging population and increasing health demands.
Newsfilter
7.5
04-09Newsfilter
Weight Watchers Launches New Medication Support Program
  • New Medication Access: Weight Watchers is now offering Eli Lilly's newly FDA-approved oral GLP-1 medication Foundayo® through its Med+ program, providing a once-daily, injection-free option for adults with obesity or overweight, thereby expanding its portfolio of FDA-approved oral GLP-1 treatments and enhancing its competitive edge in health management.
  • Clinical Support System: Med+ members will have access to the new medication under the guidance of board-certified clinicians, along with insurance support and additional tools designed to aid their treatment journey, demonstrating Weight Watchers' commitment to providing comprehensive health management solutions.
  • Success Program Impact: Med+ members who engaged with the GLP-1 Success Program for 12 months lost an average of 29.1% more body weight compared to those who did not participate, indicating the program's effectiveness in promoting health management and weight control.
  • Market Demand Response: As more individuals seek GLP-1 medications, Weight Watchers is actively responding to market demand by leveraging its clinical credibility and expertise in behavior change, aiming to provide diverse treatment options for members and drive the evolution of health management models.
moomoo
5.0
04-09moomoo
Weight Watchers Stock Rises 5.1% Following Inclusion of Eli Lilly's Oral Weight-Loss Medication in Program
  • Stock Performance: Weight Watchers shares have decreased by 5.1% following the announcement of their new weight-loss pill program.

  • New Product Launch: The company has introduced a weight-loss pill called "Eli Lilly's Oral Weight-Loss Pill" as part of their program.

moomoo
5.0
04-09moomoo
Weight Watchers Stock Soars 15% in Premarket Trading Following Launch of Eli Lilly's New Oral Medication
  • Stock Market Reaction: Weight Watchers shares surged by 15% in pre-market trading following the launch of their new oral drug.
  • Product Launch Impact: The significant increase in stock value indicates positive investor sentiment towards the new product offering by Weight Watchers.
moomoo
5.0
04-09moomoo
Weight Watchers Introduces Eli Lilly's New Oral GLP-1 Foundayo® via LillyDirect
  • Product Launch: Weight Watchers has launched a new oral GLP-1 medication called Dayo® through its subsidiary, LILLY.

  • Availability: The new medication is available directly through the LILLY platform, expanding Weight Watchers' offerings in weight management solutions.

Wall Street analysts forecast WW stock price to rise
1 Analyst Rating
Wall Street analysts forecast WW stock price to rise
0 Buy
1 Hold
0 Sell
Hold
Current: 0.000
sliders
Low
38.00
Averages
38.00
High
38.00
Current: 0.000
sliders
Low
38.00
Averages
38.00
High
38.00
Morgan Stanley
Equal Weight
downgrade
$21
AI Analysis
2026-04-01
Reason
Morgan Stanley
Price Target
$21
AI Analysis
2026-04-01
downgrade
Equal Weight
Reason
Morgan Stanley lowered the firm's price target on WW to $21 from $34.50 and keeps an Equal Weight rating on the shares. A mix shift from behavioral to clinic is happening far faster than the firm anticipated, but this comes with upside as well as "negative trade-offs," the analyst tells investors.
Morgan Stanley
Equal Weight
downgrade
$41 -> $38
2025-11-07
Reason
Morgan Stanley
Price Target
$41 -> $38
2025-11-07
downgrade
Equal Weight
Reason
Morgan Stanley lowered the firm's price target on WW to $38 from $41 and keeps an Equal Weight rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for WW
Unlock Now

Valuation Metrics

The current forward P/E ratio for WW International Inc (WW.O) is 74.07, compared to its 5-year average forward P/E of -8.95. For a more detailed relative valuation and DCF analysis to assess WW International Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-8.95
Current PE
74.07
Overvalued PE
145.08
Undervalued PE
-162.98

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
11.08
Current EV/EBITDA
11.81
Overvalued EV/EBITDA
15.17
Undervalued EV/EBITDA
6.99

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.56
Current PS
0.15
Overvalued PS
1.10
Undervalued PS
0.01

Financials

AI Analysis
Annual
Quarterly

Whales Holding WW

A
Aristeia Capital, LLC
Holding
WW
+2.09%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is WW International Inc (WW) stock price today?

The current price of WW is 9.12 USD — it has decreased -8.8

What is WW International Inc (WW)'s business?

WW International, Inc. provides science-backed weight loss and weight management programs. The Company provides an accessible, holistic model of care through its doctor-recommended Points Program, clinical interventions including weight-loss medications, and community support. Its weight-loss and weight management programs are focused on nutritional and behavior change science. They are comprised of a range of science-based nutritional, activity, behavioral and lifestyle tools and approaches that can be tailored for individual weight goals and, if needed, support the various needs of people taking GLP-1 medications. Its offerings include Behavior Change Programs, WeightWatchers Clinic, Licensing and Consumer Product Sales. Its subscription businesses include digital business, workshops + digital business, clinical business and WeightWatchers for business offering nutritional and behavior change science. Its WW-branded products include bars, snacks, cookbooks and kitchen tools.

What is the price predicton of WW Stock?

Wall Street analysts forecast WW stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for WW is38.00 USD with a low forecast of 38.00 USD and a high forecast of 38.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is WW International Inc (WW)'s revenue for the last quarter?

WW International Inc revenue for the last quarter amounts to 162.81M USD, decreased -11.71

What is WW International Inc (WW)'s earnings per share (EPS) for the last quarter?

WW International Inc. EPS for the last quarter amounts to -0.58 USD, decreased -287.10

How many employees does WW International Inc (WW). have?

WW International Inc (WW) has 3500 emplpoyees as of April 22 2026.

What is WW International Inc (WW) market cap?

Today WW has the market capitalization of 99.96M USD.